We are live on
!
Find out more
Corcept Therapeutics
CORT
CORT
96 hedge funds and large institutions have $199M invested in Corcept Therapeutics in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
1,988% more call options, than puts
Call options by funds: $167K | Put options by funds: $8K
52% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 23
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
8% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 12
1% less funds holding
Funds holding: 97 → 96 (-1)
7% less capital invested
Capital invested by funds: $215M → $199M (-$16M)
Holders
96
Holders Change
-1
Holders Change %
-1.03%
% of All Funds
2.56%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
11
Increased
35
Reduced
23
Closed
12
Calls
$167K
Puts
$8K
Net Calls
+$159K
Net Calls Change
-$405K
Top Buyers
Top Sellers
| 1 |
TC
TFS Capital
West Chester,
Pennsylvania
|
-$1.39M |
| 2 |
Renaissance Technologies
New York
|
-$1.05M |
| 3 |
Millennium Management
New York
|
-$724K |
| 4 |
D.E. Shaw & Co
New York
|
-$644K |
| 5 |
Two Sigma Investments
New York
|
-$376K |
